Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Other Non Operating Income (2018 - 2025)

TransMedics has reported Other Non Operating Income over the past 8 years, most recently at $3.7 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at $3.7 million for Q4 2025, up 93.84% from a year ago — trailing twelve months through Dec 2025 was $12.7 million (changed 0.22% YoY), and the annual figure for FY2025 was $12.7 million, changed 0.22%.
  • Other Non Operating Income for Q4 2025 was $3.7 million at TransMedics, up from $3.2 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for TMDX hit a ceiling of $5.0 million in Q3 2023 and a floor of -$1.1 million in Q3 2022.
  • Median Other Non Operating Income over the past 5 years was $2.2 million (2023), compared with a mean of $1.8 million.
  • Biggest five-year swings in Other Non Operating Income: plummeted 558.48% in 2022 and later skyrocketed 564.31% in 2023.
  • TransMedics' Other Non Operating Income stood at -$345000.0 in 2021, then soared by 414.49% to $1.1 million in 2022, then skyrocketed by 348.39% to $4.9 million in 2023, then tumbled by 60.62% to $1.9 million in 2024, then surged by 93.84% to $3.7 million in 2025.
  • The last three reported values for Other Non Operating Income were $3.7 million (Q4 2025), $3.2 million (Q3 2025), and $3.1 million (Q2 2025) per Business Quant data.